| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 06/11/2009 | CA2706920A1 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid |
| 06/10/2009 | EP2067777A1 Oxepin derivative |
| 06/10/2009 | EP2066657A1 Substituted oxindole derivatives and their use as vasopressin and/or oxytocin receptor ligands |
| 06/10/2009 | EP2066654A1 N-(1-hetarylpiperidin-4-yl)(het)arylamides as ep2 receptor modulators |
| 06/10/2009 | EP2066653A1 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents |
| 06/10/2009 | EP2066318A2 Oxindole derivatives as anticancer agents |
| 06/10/2009 | EP1597251B1 Pyrimidine compounds |
| 06/10/2009 | EP1414797B9 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 06/10/2009 | EP0976737B1 Pyrazole derivatives, process for preparing the same, intermediates, and pest control agent containing the same as active ingredient |
| 06/10/2009 | EP0854870B1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 06/10/2009 | CN101454317A Imidazole derivatives as nitric oxide synthase dimerisation inhibitor |
| 06/10/2009 | CN101454316A Substituted enaminocarbonyl compounds used as insecticides |
| 06/10/2009 | CN101454315A Reagents useful for synthesizing rhodamine-labeled oligonucleotides |
| 06/10/2009 | CN101450942A Method for producing cistofuran monohydrate |
| 06/10/2009 | CN101450941A Cistofuran synthesis and purification method |
| 06/10/2009 | CN101450940A Method for producing cistofuran large particle crystal |
| 06/10/2009 | CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/10/2009 | CN100497334C Indole derivatives useful as histamine h3 antagonists |
| 06/10/2009 | CN100497314C Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them |
| 06/09/2009 | US7544812 For example, 2-(4-{2-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-ethoxy}-2-methyl-phenoxy)-2-methyl-propionic acid, 2-(4-{3-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-propyl}-2-methyl-phenoky)-2-methyl-propionic acid; for treating diabetes mellitus |
| 06/09/2009 | US7544803 2-(2,2,2-Trifluoro-ethyl)-1,2,3,4-tetrahydro-isoquinoline-6-carboxylic acid quinolin-7-ylamides; treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, arthritis, gastrointestinal disorders |
| 06/09/2009 | US7544717 2-amino- and 2-thio- substituted 1,3-diaminopropanes |
| 06/09/2009 | US7544709 Derivatives of andrimide and moiramide B having antibacterial properties |
| 06/09/2009 | US7544708 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 06/09/2009 | US7544703 N-(3,5-Dimethylphenyl)-2-[2-(4-methylpiperazin-1-yl)pyridin-4-ylmethylthio]pyridine-3-carboxamide; 2-(2-Cyclopropylaminopyridin-4-ylmethylthio)-N-(3,5-dimethylphenyl)pyridine-3-carboxamide; cancer, rheumatoid arthritis, age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity |
| 06/09/2009 | US7544690 MCH receptor antagonists |
| 06/09/2009 | US7544686 Piperazinylalkylpyrazole derivatives useful as selective T-type calcium channel blockers and preparation method thereof |
| 06/09/2009 | US7544682 cancer; Methyl 5-((7-(((tert-butylamino)carbonyl)amino)-6-(2,6-dichlorophenyl)pyrido[2,3-d] pyrimidin-2-yl)amino)-1,3-benzodioxole-2-carboxylate; treating cellular proliferation disorders |
| 06/09/2009 | US7544675 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions |
| 06/09/2009 | CA2583764C Thrombopoietin activity modulating compounds and methods |
| 06/09/2009 | CA2355720C New substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines |
| 06/04/2009 | WO2009070172A1 Curable resins containing acetal, ketal, acetal ester, or ketal ester linkages |
| 06/04/2009 | WO2009069833A1 Aza compounds and production method thereof, and metal complexes as mri contrast agents. |
| 06/04/2009 | WO2009069044A1 Pyrazole derivatives as 5-lo inhibitors |
| 06/04/2009 | WO2009068468A2 Pyridine compounds |
| 06/04/2009 | WO2009004427A3 Benzimidazole derivatives |
| 06/04/2009 | US20090143593 Synthesis of heterocyclic compounds |
| 06/04/2009 | US20090143575 Vanilloid receptor ligands and their use in treatments |
| 06/04/2009 | US20090143459 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 06/04/2009 | US20090143443 Cyclic amine compound and pest control agent |
| 06/04/2009 | US20090143437 Ep4 receptor antagonists |
| 06/04/2009 | US20090143432 Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof |
| 06/04/2009 | US20090143429 Quinoline Derivatives as Neurokinin Receptor Antagonists |
| 06/04/2009 | US20090143422 P38 inhibitors and methods of use thereof |
| 06/04/2009 | US20090143408 Compositions and methods for inhibiting cytochrome p450 2d6 |
| 06/04/2009 | US20090143406 New Phenylpiperazine |
| 06/04/2009 | US20090143395 Piperazine Derivatives |
| 06/04/2009 | US20090143384 2,4,6-Trisubstituted Pyrimidines as Phosphotidylinositol (Pi) 3-Kinase Inhibitors and Their Use in the Treatment of Cancer |
| 06/04/2009 | US20090143381 Modulators of atp-binding cassette-transporters |
| 06/04/2009 | US20090143370 Non-nucleoside Reverse Transcriptase Inhibitors |
| 06/04/2009 | US20090143232 Method for synthesising templated molecules |
| 06/04/2009 | CA2706576A1 Pyridine compounds |
| 06/03/2009 | EP2065384A1 Tricyclic thrombin receptor antagonist |
| 06/03/2009 | EP2065379A1 Benzimidazole compound having gastric acid secretion inhibitory activity |
| 06/03/2009 | EP2065377A1 Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same |
| 06/03/2009 | EP2065369A1 Urea compound or salt thereof |
| 06/03/2009 | EP2065368A1 Inhibitors of IAP |
| 06/03/2009 | EP2064205A2 Improved method for preparing 1,3-disubstituted pyrrolidine compounds |
| 06/03/2009 | EP2064190A1 Pyrimidylmethyl-sulfonamide compounds useful as fungicides and against arthropods |
| 06/03/2009 | EP2064185A1 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions |
| 06/03/2009 | EP1910310B1 Novelimidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same |
| 06/03/2009 | EP1765788B1 3-aminoindazole derivatives and their use for the treatment of sgk-associated diseases |
| 06/03/2009 | EP1263720B1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same |
| 06/03/2009 | EP1165553B1 C10 ester substituted taxanes as antitumor agents |
| 06/03/2009 | EP1071668B1 5-aminoindeno[1,2-c]pyrazol-4-ones as anti-cancer and anti-proliferative agents |
| 06/03/2009 | CN101448824A 2,5-disubstituted piperidines |
| 06/03/2009 | CN101445504A Dioxane-2-alkyl carbamates derivatives |
| 06/03/2009 | CN101445486A Derivatives of aryl-quinazoline/aryl-2-amino-phenyl methanone which promote the release of parathyroid hormone |
| 06/03/2009 | CN100494203C Functionalized ionic liquids, and methods of use thereof |
| 06/03/2009 | CN100494182C Regulatory factor of tumor necrosis alpha factor |
| 06/03/2009 | CN100494180C Preparation method and uses of isoquinolinium compound and its salt |
| 06/02/2009 | US7542575 Digital sound processing system for a vehicle |
| 06/02/2009 | US7541471 preparation of a thrombin receptor antagonist by chemical reduction, cyclization, hydrolysis, amination, and salt formation; easy purification by crystallization, scalability, and improve process yield; antiinflammatory agent, anticoagulants, antiproliferative agent for fibrosuppression; atherosclerosis |
| 06/02/2009 | US7541463 Lung cancer, gastric cancer, liver cancer, leucocythemia, endometrioma, oophoroma, mammary cancer, colon cancer, prostatic cancer, or pituitary gland cancer; N (N',N'-dimethylaminoethyl)benzo[b]thieno[2,1-c]naphthalimide |
| 06/02/2009 | US7541375 Azole derivatives and pharmaceutical compositions containing them |
| 06/02/2009 | US7541369 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2009 | US7541368 Pyrazoles as inhibitors of tumor necrosis factor |
| 06/02/2009 | US7541358 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 06/02/2009 | US7541096 Blue emitting, durable, organoelectrouminescent layers containing 2H-benzotriazole compounds; full color display panels; light emission efficiency and brightness |
| 06/02/2009 | CA2434277C Substituted alkylamine derivatives and methods of use |
| 06/02/2009 | CA2399125C Process for the preparation of 5-arylnicotinaldehydes |
| 06/02/2009 | CA2362594C Process for the production of tert-butyl (e)-(6-[2- [4-(4-fluorophenyl) -6-isopropyl-2-[ methyl (methylsulfonyl) amino] pyrimidin-5-yl] vinyl](4r, 6s)-2,2-dimethyl [1,3]dioxan-4-yl) acetate |
| 06/02/2009 | CA2344290C Quinazoline derivatives |
| 06/02/2009 | CA2287551C 3-(2-pyrrolidinylmethyl)-indole compounds having 5-ht6 affinity |
| 06/02/2009 | CA2258539C Ring-fused dihydropyranes, process for the preparation and use thereof |
| 05/28/2009 | WO2009067406A1 Substituted pyridyl amide compounds as modulators of the histamine h3 receptor |
| 05/28/2009 | WO2009067405A1 Substituted pyrazinyl amide compounds as modulators of the histamine h3 receptor |
| 05/28/2009 | WO2009067035A2 Method of obtaining of 4-n-furfurylcytosine and/or its derivatives, an anti-aging composition and use of 4-n-furfurylcytosine and/or its derivatives in the manufacture of anti-aging composition |
| 05/28/2009 | WO2009065503A1 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
| 05/28/2009 | WO2009065169A1 Insulin-regulated aminopeptidase (irap) inhibitors and uses thereof |
| 05/28/2009 | WO2009026657A8 Flavonoid ppar agonists |
| 05/28/2009 | US20090137795 New route to formyl-porphyrins |
| 05/28/2009 | US20090137629 Sigma receptor binding agent containing indanone derivative |
| 05/28/2009 | US20090137611 Fungicide N-Cyclopropyl-Sulfonylamide Derivatives |
| 05/28/2009 | US20090137603 Heterocyclic amide compound and use thereof |
| 05/28/2009 | US20090137588 Heteroaryl compounds and uses thereof |
| 05/28/2009 | US20090137576 Novel Piperidine Derivative |
| 05/28/2009 | US20090137566 Substituted Piperdines as Renin Inhibitors |
| 05/28/2009 | US20090136596 P38 inhibitors and methods of use thereof |
| 05/28/2009 | US20090134784 Carbazole-containing materials in phosphorescent light emitting diodes |